Douglas Semler, MD
Dermatology · Lansdowne, VANPI 1467403600
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Galderma Laboratories, L.p. accounts for 69.0% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $10,100 and has fallen 87.8% since, to $1,233 in 2025. Among dermatology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $109.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$17K
- Johnson & Johnson$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
- AbbVie$559
- E.r. Squibb & Sons, L.L.C.$509
- Dermavant Sciences, Inc.$410
- plus $3K from 23 others
What the payments were for
- Consulting fees$4,60019%
- Speaking & faculty fees$10,46044%
- Travel & lodging$8484%
- Food & beverage$8,09334%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 49 | $16,564 |
| Johnson & Johnson | 5 | $1,697 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 33 | $1,477 |
| AbbVie(2 entities) | 13 | $559 |
| E.r. Squibb & Sons, L.L.C. | 7 | $509 |
| Dermavant Sciences, Inc. | 11 | $410 |
| Incyte Corporation | 6 | $379 |
| Pfizer | 12 | $361 |
| Sun Pharmaceutical Industries Inc. | 9 | $287 |
| Arcutis Biotherapeutics, Inc. | 9 | $267 |
| Novartis | 6 | $185 |
| Sanofi | 7 | $185 |
| UCB, Inc. | 6 | $179 |
| Lilly USA, LLC | 5 | $120 |
| Almirall LLC | 6 | $110 |
| Journey Medical Corporation | 7 | $89 |
| Mayne Pharma Commercial LLC | 4 | $80 |
| LEO Pharma Inc. | 3 | $70 |
| Convatec Inc. | 1 | $69 |
| Bristol Myers Squibb | 2 | $69 |
| DUSA Pharmaceuticals, Inc. | 3 | $60 |
| Encore Dermatology Inc. | 3 | $58 |
| Botanix SB Inc | 3 | $57 |
| Dermira, Inc. | 2 | $55 |
| Organon | 3 | $51 |
| EPI Health, LLC | 1 | $23 |
| Merck | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,016 in reported general payments places this provider in the 90th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $52,092 |
| OraceaDoxycycline Monohydrate | 13 | $19,803 |
| Clobetasol Propionate | 47 | $3,461 |
| Fluocinonide | 83 | $3,163 |
| Metronidazole | 32 | $2,345 |
| Doxycycline Hyclate | 88 | $1,734 |
| Triamcinolone Acetonide | 116 | $1,449 |
| Clindamycin Phosphate | 16 | $1,157 |
| Fluorouracil | 22 | $1,049 |
| Econazole Nitrate | 30 | $883 |
| Ciclopirox | 32 | $744 |
| Mupirocin | 49 | $699 |
| ValacyclovirValacyclovir Hcl | 33 | $642 |
| Ketoconazole | 54 | $603 |
| Mometasone Furoate | 24 | $540 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Galderma Laboratories, L.p.Oracea | $16,564 | $19,80313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 396 dermatology providers in Virginia.
Other dermatology in Lansdowne
- Keri ChurchLansdowne$16K
- Meredith HelserLansdowne$14K
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.